174 related articles for article (PubMed ID: 28293970)
1. CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma.
Galicia N; Dégano R; Díez P; González-González M; Góngora R; Ibarrola N; Fuentes M
Expert Rev Proteomics; 2017 Apr; 14(4):363-372. PubMed ID: 28293970
[TBL] [Abstract][Full Text] [Related]
2. Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications.
Galicia N; Díez P; Dégano RM; Guest PC; Ibarrola N; Fuentes M
Adv Exp Med Biol; 2017; 974():85-96. PubMed ID: 28353226
[TBL] [Abstract][Full Text] [Related]
3. The Combined Performance of ADC, CSF CXC Chemokine Ligand 13, and CSF Interleukin 10 in the Diagnosis of Central Nervous System Lymphoma.
Mabray MC; Barajas RF; Villanueva-Meyer JE; Zhang CA; Valles FE; Rubenstein JL; Cha S
AJNR Am J Neuroradiol; 2016 Jan; 37(1):74-9. PubMed ID: 26381553
[TBL] [Abstract][Full Text] [Related]
4. Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis.
Rimelen V; Ahle G; Pencreach E; Zinniger N; Debliquis A; Zalmaï L; Harzallah I; Hurstel R; Alamome I; Lamy F; Voirin J; Drénou B
Acta Neuropathol Commun; 2019 Mar; 7(1):43. PubMed ID: 30885253
[No Abstract] [Full Text] [Related]
5. Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.
Strehlow F; Bauer S; Martus P; Weller M; Roth P; Schlegel U; Seidel S; Scheibenbogen C; Korfel A; Kreher S
J Neurooncol; 2016 Aug; 129(1):165-71. PubMed ID: 27294357
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement.
Hansen PB; Kjeldsen L; Dalhoff K; Olesen B
Acta Neurol Scand; 1992 Mar; 85(3):224-7. PubMed ID: 1575009
[TBL] [Abstract][Full Text] [Related]
7. MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.
Ferreri AJM; Calimeri T; Lopedote P; Francaviglia I; Daverio R; Iacona C; Belloni C; Steffanoni S; Gulino A; Anghileri E; Diffidenti A; Finardi A; Gagliardi F; Anzalone N; Nonis A; Furlan R; De Lorenzo D; Terreni MR; Martinelli V; Sassone M; Foppoli M; Angelillo P; Guggiari E; Falini A; Mortini P; Filippi M; Tarantino V; Eoli M; Ciceri F; Doglioni C; Tripodo C; Locatelli M; Cangi MG; Ponzoni M
Br J Haematol; 2021 May; 193(3):497-505. PubMed ID: 33620087
[TBL] [Abstract][Full Text] [Related]
8. Higher levels of progranulin in cerebrospinal fluid of patients with lymphoma and carcinoma with CNS metastasis.
Kimura A; Takemura M; Serrero G; Yoshikura N; Hayashi Y; Saito K; Inuzuka T
J Neurooncol; 2018 May; 137(3):455-462. PubMed ID: 29340960
[TBL] [Abstract][Full Text] [Related]
9. Protein biomarker identification in the CSF of patients with CNS lymphoma.
Roy S; Josephson SA; Fridlyand J; Karch J; Kadoch C; Karrim J; Damon L; Treseler P; Kunwar S; Shuman MA; Jones T; Becker CH; Schulman H; Rubenstein JL
J Clin Oncol; 2008 Jan; 26(1):96-105. PubMed ID: 18056677
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid Flow Cytometry: Utility in Central Nervous System Lymphoma Diagnosis.
Au KLK; Latonas S; Shameli A; Auer I; Hahn C
Can J Neurol Sci; 2020 May; 47(3):382-388. PubMed ID: 32228724
[TBL] [Abstract][Full Text] [Related]
11. A systematic approach to the diagnosis of suspected central nervous system lymphoma.
Scott BJ; Douglas VC; Tihan T; Rubenstein JL; Josephson SA
JAMA Neurol; 2013 Mar; 70(3):311-9. PubMed ID: 23319132
[TBL] [Abstract][Full Text] [Related]
12. Multi-marker algorithms based on CXCL13, IL-10, sIL-2 receptor, and β2-microglobulin in cerebrospinal fluid to diagnose CNS lymphoma.
Maeyama M; Sasayama T; Tanaka K; Nakamizo S; Tanaka H; Nishihara M; Fujita Y; Sekiguchi K; Kohta M; Mizukawa K; Hirose T; Itoh T; Kohmura E
Cancer Med; 2020 Jun; 9(12):4114-4125. PubMed ID: 32314548
[TBL] [Abstract][Full Text] [Related]
13. Cytology of primary central nervous system neoplasms in cerebrospinal fluid specimens.
Chhieng DC; Elgert P; Cohen JM; Jhala NC; Cangiarella JF
Diagn Cytopathol; 2002 Apr; 26(4):209-12. PubMed ID: 11933264
[TBL] [Abstract][Full Text] [Related]
14. The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients.
Nguyen-Them L; Costopoulos M; Tanguy ML; Houillier C; Choquet S; Benanni H; Elias-Shamieh R; Armand M; Faivre G; Glaisner S; Malak S; Vargaftig J; Hoang-Xuan K; Ahle G; Touitou V; Cassoux N; Davi F; Merle-Béral H; Le Garff-Tavernier M; Soussain C;
Eur J Cancer; 2016 Jul; 61():69-76. PubMed ID: 27156226
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread.
Spreafico F; Bongarzone I; Pizzamiglio S; Magni R; Taverna E; De Bortoli M; Ciniselli CM; Barzanò E; Biassoni V; Luchini A; Liotta LA; Zhou W; Signore M; Verderio P; Massimino M
Oncotarget; 2017 Jul; 8(28):46177-46190. PubMed ID: 28526811
[TBL] [Abstract][Full Text] [Related]
16. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.
Viaccoz A; Ducray F; Tholance Y; Barcelos GK; Thomas-Maisonneuve L; Ghesquières H; Meyronet D; Quadrio I; Cartalat-Carel S; Louis-Tisserand G; Jouanneau E; Guyotat J; Honnorat J; Perret-Liaudet A
Neuro Oncol; 2015 Nov; 17(11):1497-503. PubMed ID: 26014047
[TBL] [Abstract][Full Text] [Related]
17. Isolated leptomeningeal infiltration of a primary CNS B-cell lymphoma diagnosed by flow cytometry and confirmed by necropsy.
Broussalis E; Hutterer M; Oppermann K; Wipfler P; Pilz G; Harrer A; Haschke-Becher E; Golaszewski S; Schönauer U; Weis S; Killer-Oberpfalzer M; Mc Coy M; Trinka E; Kraus J
Acta Neurol Scand; 2012 Sep; 126(3):e11-6. PubMed ID: 22211863
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid approach on neuro-oncology.
Gomes HR
Arq Neuropsiquiatr; 2013 Sep; 71(9B):677-80. PubMed ID: 24141503
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of cerebrospinal fluid cytology in comparison with tumor marker activity in central nervous system metastases secondary to breast cancer.
Bach F; Bjerregaard B; Sölétormos G; Bach FW; Horn T
Cancer; 1993 Oct; 72(8):2376-82. PubMed ID: 8402452
[TBL] [Abstract][Full Text] [Related]
20. CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma.
Ikeguchi R; Shimizu Y; Shimizu S; Kitagawa K
Mult Scler; 2018 Aug; 24(9):1212-1223. PubMed ID: 28657431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
